Brief: Toleranzia Drug Candidate Has Positive Results Published

Toleranzia AB

03/06/2022 09:31

June 3 (Reuters) - Toleranzia AB  TOLE.ST :
    * POSITIVE RESULTS FOR TOLERANZIA'S DRUG CANDIDATE TOL2
PUBLISHED
IN REPUTABLE SCIENTIFIC JOURNAL
    * STUDY RESULTS SHOW THAT INTRAVENOUS TREATMENT WITH TOL2
EFFECTIVELY AND SUSTAINABLY REDUCES ALL DISEASE SYMPTOMS IN A
PRECLINICAL MYASTHENIA GRAVIS MODEL
    * COMPARATIVE ANALYSIS ALSO SHOWED THAT TREATMENT EFFECT OF
DRUG
CANDIDATE FAR EXCEEDED THAT OF TWO ESTABLISHED TREATMENTS FOR
MYASTHENIA GRAVIS

Source text for Eikon:  ID:nMFN9Z0Vbx 
Further company coverage:  TOLE.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))